ARCHIVES

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group Meetings for July

June 27, 1975

FDA Hazleton Probe Finds Some Problems; Results Unaffected

April 23, 1976

NCI Advisors Approve Center Grants For Research On Health Disparities.

November 30, 2001

In Brief: Hutchinson Begins Prostate Cancer Study; Meyer Named GWU Medical Dean; Nurses Win VA Posts

April 9, 1993

NCI Statisticians Disputes Bross Claim

April 27, 1979

Certification Means More Money for Nurses, ONS Finds

June 29, 1990